J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brun, P.
Right arrow Articles by Castagliuolo, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brun, P.
Right arrow Articles by Castagliuolo, I.
Agricola
Right arrow Articles by Brun, P.
Right arrow Articles by Castagliuolo, I.
J Med Microbiol 57 (2008), 725-731; DOI: 10.1099/jmm.0.47736-0
© 2008 Society for General Microbiology
ISSN 1473-5644

Clostridium difficile TxAC314 and SLP-36kDa enhance the immune response toward a co-administered antigen

Paola Brun1, Melania Scarpa1, Alessia Grillo1, Giorgio Palù1, Carlo Mengoli1, Alfonso Zecconi2, Patrizia Spigaglia3, Paola Mastrantonio3 and Ignazio Castagliuolo1

1 Department of Histology, Microbiology and Medical Biotechnologies, University of Padua, Padua, Italy

2 Department of Animal Pathology, Hygiene and Health, University of Milan, Milan, Italy

3 Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome, Italy

Correspondence
Ignazio Castagliuolo
ignazio.castagliuolo{at}unipd.it

Received 31 October 2007
Accepted 19 December 2007


This study evaluated the in vivo adjuvant activity of two peptides derived from Clostridium difficile: a fragment of the receptor-binding domain of toxin A (TxAC314) and a fragment of the 36 kDa surface-layer protein (SLP-36kDa) from strain C253. Their ability to affect the magnitude, distribution and polarization of the immune response against fibronectin-binding protein A (FnbpA), a protective vaccine antigen against Staphylococcus aureus, was evaluated using two different routes of immunization: intranasal and subcutaneous. It was shown that (i) the route of immunization affected the magnitude of the immune response; (ii) both peptides enhanced the production of circulating anti-FnbpA IgG and IgA; (iii) following mucosal immunization TxAC314 was more effective than SLP-36kDa at inducing antibody in the gastrointestinal tract; (iv) the adjuvant influenced the Th1/Th2 balance; and (v) TxAC314 was more effective than SLP-36kDa in inducing a cell-mediated response. These studies provide insight into the ability of different C. difficile-derived peptides to differentially affect and polarize the activity of the immune system and on their potential use as adjuvants in newly developed vaccines.


Abbreviations: CT, cholera toxin; DC, dendritic cell; FnbpA, fibronectin-binding protein A; IFN-{gamma}, gamma interferon; IL-2, interleukin-2; i.m., intramuscularly; i.n., intranasally; LT, heat-labile enterotoxin; s.c., subcutaneously; SLP, surface-layer protein; SLP-36kDa, fragment of the 36kDa SLP; TcdA, toxin A.




This article has been cited by other articles:


Home page
J Med MicrobiolHome page
I. R. Poxton
Proceedings from the 2nd International Clostridium difficile Symposium, Maribor, Slovenia, June 2007.
J. Med. Microbiol., June 1, 2008; 57(Pt 6): 683 - 794.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2008 Society for General Microbiology.